Wenjin Liang - Publications

HepAssis2® bioartificial liver system in treating acute-on-chronic liver failure patients: Findings from a phase 1 randomised, open-label clinical trial.

Journal: Clinical and translational medicine

Published: November 17, 2025

End-Ischemic Hypothermic Oxygenated Perfusion Attenuates Ischemia Reperfusion Injury to Rat Livers Donated After Cardiac Death Through the Regulation of Protein Phosphatase 2A Related Apoptosis and Autophagy.

Journal: Transplantation proceedings

Published: July 16, 2025

Clinical performance evaluation of a plasma dual-target methylation test for the detection of primary liver cancer: a multicenter study.

Journal: Clinical epigenetics

Published: April 17, 2025

Mediating effects of attitude on the relationship between knowledge and willingness to organ donation among nursing students.

Journal: Frontiers in public health

Published: January 15, 2024

Case report: A successful clinical experience of transplantation of liver and kidney from a donor with myelodysplastic syndromes.

Journal: Frontiers in immunology

Published: January 09, 2024

Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 19, 2023

Hypothermic machine perfusion reduces donation after circulatory death liver ischemia-reperfusion injury through the SERPINA3-mediated PI3Kδ/Akt pathway.

Journal: Human cell

Published: June 22, 2023

Hemoperfusion Adsorbents for Removal of Common Toxins in Liver and Kidney Failure: Recent Progress, Challenges, and Prospects.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: May 30, 2023

Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma.

Journal: Molecules (Basel, Switzerland)

Published: January 31, 2023

Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma.

Journal: Frontiers in genetics

Published: October 10, 2022

M6A-Mediated Upregulation of LINC00106 Promotes Stemness and Metastasis Properties of Hepatocellular Carcinoma via Sponging Let7f.

Journal: Frontiers in cell and developmental biology

Published: September 23, 2021

MMP7 damages the integrity of the renal tubule epithelium by activating MMP2/9 during ischemia-reperfusion injury.

Journal: Journal of molecular histology

Published: April 24, 2020